Reset filters
  • 11 April 2014

Sofosbuvir/ledipasvir is safe and effective for relapsers and hard-to-treat patients

Read the article
Edward Gane of Auckland Clinical Studies, New Zealand, presenting at EASL 2014; photo by Liz Highleyman, hivandhepatitis.com
  • 10 April 2014

88% of previous relapsers achieve hepatitis C cure with simeprevir-based triple therapy

Read the article
Xavier Forns speaking at the International Liver Congress 2014. Photo by Liz Highleyman, hivandhepatitis.com.
  • 10 April 2014

AbbVie interferon-free regimen cures 96% of treatment-experienced genotype 1 hepatitis C infections

Read the article
Professor Stefan Zeuzem speaking at the International Liver Congress 2014. Photo by Liz Highleyman, hivandhepatitis.com.
  • 10 April 2014

Can we provide point-of-care viral load tests in poor countries?

Read the article
  • 9 April 2014

PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors

Read the article
  • 9 April 2014

WHO recommends global use of newest hepatitis C drugs, urges price reductions

Read the article
WHO recommends global use of newest hepatitis C drugs, urges price reductions
  • 9 April 2014

Low CD4 count during HIV therapy increases risk of virus-related non-AIDS cancers

Read the article
  • 8 April 2014

Giving treatment to specific high-risk people may bring down HIV faster than distributing it equally

Read the article
  • 7 April 2014

Expanded HIV testing may find more acute infections as well as more late presenters

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.